in-hospital mortality; careful selection of oxygen saturation targets in clinical practice is also warranted.
A Step-up Approach, or Open Necrosectomy for Necrotizing Pancreatitis
To 1 show that percutaneous drainage (PCD) alone is a valuable strategy in selected patients, helping to avoid the need for surgery in 40% of step-up patients.
The reduced morbidity associated with the procedure may largely be due to the avoidance of harm from surgery: when PCD-only patients are not considered, the complication rate appears to be similar in the two study groups. Moreover, PCD was often inadequate, leading to a delay in source control. Since PCD appears to be less successful in patients with multiple organ failure, 2 and since mortality dramatically increased when it was used as a sole strategy for these patients, 3 an important element of the treatment is potentially delayed. Early identification of patients who will not be helped by PCD is desirable.
Rather than using a step-up approach for all patients, a strategy tailored to the patient's specific needs, based on the results of computed tomography and on clinical condition, using the source-control strategy most likely to adequately drain collected fluid and débride infected necrotic tissue may be the best approach after all. PCD, video-assisted retroperitoneal débridement, and open necrosectomy may all be effective tools to use in reaching this goal. To the Editor: The PANTER study group teaches us that "minimally" invasive surgery is associated with a lower morbidity than open necrosectomy in patients who have necrotizing pancreatitis with infected necrotic tissue. Although this article is a milestone in the surgical literature, its results are disappointing. There was no significant difference in the mortality of the two study groups (16% vs. 19%) despite the fact that intervention was withheld for at least 4 weeks. The complications in the group receiving "minimally" invasive treatment included enterocutaneous fistulas (in 22% of patients), intra-abdominal bleeding (16%), pancreatic fistulas (28%), and incisional hernias (7%). 1 The surgery these patients received was clearly not "minimally" invasive.
But is there another approach? Does infected necrotic tissue need drainage at all? Several case reports and series have recorded reasonable survival rates among patients treated with antibiotics alone. [1] [2] [3] [4] Now that withholding intervention for at least 4 weeks seems to be ensconced in good surgical practice, perhaps a longer wait, coupled with the judicious use of antibiotics, can 
The Authors Reply:
We first want to clarify several issues discussed by Dr. Andrew Warshaw in the editorial he wrote about our article. 1 Warshaw stated that the step-up approach has narrow applicability. This is not correct. The feasibility of the step-up approach was 98%, with just one patient excluded because a drain could not be placed. Warshaw also stated that the feasibility of using a retroperitoneal access route was a criterion for inclusion in the trial. This was not the case: percutaneous or endoscopic catheter drainage of fluid could proceed through any route (retroperitoneal, transabdominal, or endoscopic transgastric). Nevertheless, a retroperitoneal access route for drainage, and if needed, video-assisted retroperitoneal débridement, was possible in 80 of the 88 patients (91%) who underwent randomization. It was also noted that the rate of death in our study (17%) compares unfavorably to rates in recent North American studies. 2, 3 This difference can probably be attributed to differences in case mix, since these studies showed lower percentages of infected necrotic tissue (72 to 74% vs. 92%) and lower preoperative scores on the Acute Physiology and Chronic Health Evaluation (APACHE) II (9.0 to 9.5 vs. 15). Notably, in the Boston study referenced by Warshaw, the rate of death among patients with infected necrotic tissue (i.e., the subgroup similar to that in our study) was 15%. 3 In his letter, De Waele suggests that PCD was often inadequate, leading to a delay in source control. However, we do not consider PCD to have failed when surgery is still needed. PCD is appreciated as a means of stabilizing sepsis and thereby improving the patient's condition for subsequent surgery. Basing his remarks on retrospective studies, De Waele also suggests that PCD is less successful in patients with multipleorgan failure. In our study, PCD was successful in 35% of patients, irrespective of single or multiple organ failure. It is also suggested that mortality increases dramatically when PCD is used as a sole strategy. This was not the case in our study: the rate of death among patients undergoing PCD only was 12% (2 patients of 17) as compared with 23% (6 of 26) among those undergoing PCD and surgery. We therefore conclude that PCD should be the first treatment whenever possible.
Steinberg suggests that the mortality rate in our study is disappointing. However, recent series from expert centers in Boston and Liverpool show similar mortality rates. 3, 4 We agree that a very small subgroup of patients with infected necrotic tissue might be treated with antibiotics alone, but this approach has been discussed only in case reports and very small series, and multiple-organ failure still develops in these patients. 5 In our study, a nationwide multidisciplinary expert panel agreed on the indication for intervention in each patient.
